Aberrant overexpression of UCK2 has been linked with poor prognosis in multiple cancers, particularly in HCC (48), and our study further confirms that elevated UCK2 expression predicts adverse clinical outcomes, underscoring its potential as a prognostic biomarker. Here, UCK2 is linked to hepatocellular carcinoma.